Cc1ccc2c(c1)CC1(C2=O)[C@H](c2ccccc2)C2C(=O)c3ccc(C)cc3C2[C@H]1c1ccccc1
The rule of three is typically followed by orally active drugs, which have a molecular weight of <300, a c LogP of ≤3, a hydrogen bond donor count of ≤3 and a hydrogen bond acceptor count of ≤3. Does the molecule comply with the rule of three?